Drug news
US CDC recommend HPV vaccine against Human Papilloma Virus for 11 or 12 year old boys
The US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices has approved recommendations for routine vaccination of 11 or 12 years old males using 3-doses of HPV4 vaccine, from Merck, to protect against Human Papalloma Virus. The HPV vaccine will provide protection against certain HPV-related conditions and cancers in males, including genital warts and oral, penile and anal cancers. In addition, vaccination of young males with HPV may also provide indirect protection of women by reducing transmission of HPV. Routine vaccination with HPV is already recommended by ACIP for females between 11 and 26 years old.